Gail P. Mazzara

High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors

Charles R. Rinaldo, Xiaoli Huang, M. Ding et al. · Journal of Virology · 1995 · 512 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

Harriet L. Robinson, David C. Montefiori, R. Paul Johnson et al. · Nature Medicine · 1999 · 380 citations

Life Sciences, Immunology, Infectious Diseases +16

A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer.

Joseph P. Eder, Philip W. Kantoff, Kristin Röper et al. · PubMed · 2000 · 296 citations

Medicine, Oncology, Radiation Oncology +17

The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals

Marylyn M. Addo, Marcus Altfeld, Eric Rosenberg et al. · Proceedings of the National Academy of Sciences · 2001 · 188 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells

R. Paul Johnson, Alicja Trocha, Gail P. Mazzara et al. · The Journal of Immunology · 1991 · 185 citations

Life Sciences, Immunology, Infectious Diseases +17